Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
Clinical trial NCT04314544 · COMPLETED
Trial details
- NCT number
- NCT04314544
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2025-03-26
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.